T-Net5h
Zymeworks Receives US FDA Approval for Ziihera and $25M 'Milestone Payment' From Jazz Pharmaceuticals (Eligible for $1 Billion+)
Embryo-Fetal Toxicity ZIIHERA can cause fetal harm when administered to a pregnant woman. In literature reports, use of a HER2-directed antibody during p ...
T-Net6h
BuildDirect.com Technologies Reports Third Quarter 2024 Financial Results
BuildDirect.com Technologies Inc. a leading omnichannel building material retailer, announced its financial results for the Third Quarter 2024. These financial results cover the three (3) and nine (9) ...
T-Net6h
D-Wave Names Sharon Holt to Board of Directors
D-Wave Quantum Inc., a leader in quantum computing systems, software, and services and the world's first commercial supplier of quantum computers, announced the appointment of Sharon Holt to its board ...
T-Net6h
Lexaria's GLP-1 Human Pilot Study #3 Completes Dosing as Scheduled
Lexaria Bioscience Corp., a global innovator in drug delivery platforms announced that dosing has been completed for human pilot study #3 investigating a DehydraTECH-processed version of the dual ...
T-Net6h
Vecima and Witke to Deploy All-PON Fiber Access Solution with LIWEST in Austria
Vecima Networks Inc. announced that LIWEST, Austria's leading cable provider, will deploy its Entra EXS1610 All-PON™ 10G shelf solution with DOCSIS® Provisioning of EPON (DPoE™) after completing a ...